Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Virology Journal
Published in: Virology Journal 1/2021

01-12-2021 | Hypercholesterolemia | Research

Association of the host genetic factors, hypercholesterolemia and diabetes with mild influenza in an Iranian population

Authors: Parvaneh Mehrbod, Sana Eybpoosh, Behrokh Farahmand, Fatemeh Fotouhi, Majid Khanzadeh Alishahi

Published in: Virology Journal | Issue 1/2021

Login to get access

Abstract

Background

Variation in host genetic factors may result in variation in the host immune response to the infection. Some chronic diseases may also affect individuals’ susceptibility to infectious diseases. The aim of this study was to evaluate the association of the host genetic factors mostly involved in inflammation, as well as hypercholesterolemia and diabetes with mild flu in an Iranian population.

Methods

In this cross-sectional study, nasopharyngeal swab samples were collected from 93 patients referred to primary care centers of Markazi, Semnan, and Zanjan provinces (central Iran) due to flu-like symptoms between March 2015 and December 2018. Of these, PCR test identified 49 influenza A/H1N1 and 44 flu-negative individuals. Twelve single-nucleotide polymorphisms (SNPs) in RPAIN, FCGR2A, MBL-2, CD55, C1QBP, IL-10, TNF-α and an unknown gene were genotyped using iPLEX GOLD SNP genotyping analysis. Hypercholesterolemia and diabetes status was determined based on the physician diagnosis. Association of the host genetic variants, hypercholesterolemia and diabetes with mild A/H1N1 flu was assessed with univariable and multivariable logistic regression analysis as implemented in Stata software (v.14). Statistical tests were considered as significant at 0.05 levels.

Results

Frequency of diabetes and hypercholesterolemia, as well as participants mean age was significantly higher in the flu-negative rather than the flu-positive group. Of 12 SNPs, nine did not show any significant association with mild flu in our study (rs1801274, rs1800451, rs2564978, rs361525, rs1800450, rs1800871, rs1800872, rs1800896, rs1800629). Possessing G vs. A allele in two SNPs (rs3786054 and rs8070740) was associated with a threefold increase in the chance of mild flu when compared to flu-negative patients (95% CI: 1.1, 22.0). Possessing C allele (vs. A) in the rs9856661 locus also increased the chance of mild flu up to 2 folds (95% CI: 1.0, 10.0).

Conclusion

The results showed that possessing the G allele in either rs3786054 or rs8070740 loci in C1QBP and RPAIN genes, respectively, increased the risk of H1N1 infection up to 3.3 folds, regardless of the patient’s age, BMI, diabetes, and hypercholesterolemia. Complementary functional genomic studies would shed more light on the underlying mechanism of human immunity associated with these genetic markers. The identified genetic factors may have the same role in susceptibility to similar respiratory infections with RNA viruses, like SARS, MERS and COVID-19. Future genetic association studies targeting these RNA viruses, especially COVID-19 is recommended. Studies on other ethnic groups would also shed light on possible ethnic variations in genetic susceptibility to respiratory RNA viruses.
Trial registry IR.PII.REC.1399.063
Literature
1.
Fedson DS. Confronting an influenza pandemic with inexpensive generic agents: can it be done? Lancet Inf Dis. 2008;8:571–6.CrossRef
2.
Herold S, Ludwig S, Pleschka S, Wolff T. Apoptosis signaling in influenza virus propagation, innate host defense, and lung injury. J Leukoc Biol. 2012;92:75–82.PubMedCrossRef
3.
4.
Aditama, T.Y., Samaan, G., Kusriastuti, R., Purba, W.H., Misriyah, Santoso, H., Bratasena, A., Maruf, A., Sariwati, E., Setiawaty, V., et al. Risk factors for cluster outbreaks of Avian influenza A H5N1 infection, Indonesia. Clinical Infectious Diseases, 2011. 53: 1237–1244.
5.
Horby P, Sudoyo H, Viprakasit V, Fox A, Thai PQ, Yu H, Davila S, Hibberd M, Dunstan SJ, Monteerarat Y, et al. What is the evidence of a role for host genetics in susceptibility to influenza A/H5N1? Epidemiol Infect. 2010;138:1550–8.PubMedCrossRef
6.
Sedyaningsih ER, Isfandari S, Setiawaty V, Rifati L, Harun S, Purba W, Imari S, Giriputra S, Blair PJ, Putnam SD, et al. Epidemiology of cases of H5N1 virus infection in Indonesia, July 2005–June 2006. J Infect Dis. 2007;196:522–7.PubMedCrossRef
7.
CDC. People at high risk of developing flu-related complications. 2017 [cited 2017].
8.
Campbell A, Rodin R, Kropp R, Mao Y, Hong Z, Vachon J, Spika J, Pelletier L. Risk of severe outcomes among patients admitted to hospital with pandemic (H1N1) influenza. Can Med Assoc J. 2010;182:349–55.CrossRef
9.
Hanslik T, Boelle PY, Flahault A. Preliminary estimation of risk factors for admission to intensive care units and for death in patients infected with A(H1N1)2009 influenza virus, France, 2009–2010. PLoS Curr. 2010;5:2157–3999.
10.
Valdez R, Narayan KMV, Geiss LS, Engelgau MM. The impact of diabetes mellitus on mortality associated with pneumonia and influenza among non-hispanic black and white US adults. Am J Public Health. 1999;89:1715–21.PubMedPubMedCentralCrossRef
11.
Webb SA, Pettilä V, Seppelt I, Bellomo R, Bailey M, Cooper DJ, Cretikos M, Davies AR, Finfer S, Harrigan PW, et al. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med. 2009;361:1925–34.PubMedCrossRef
12.
Ribeiro, A.F., Pellini, A.C.G., Kitagawa, B.Y., Marques, D., Madalosso, G., N.F.G., d.C., Fred, J., Albernaz, R.K.M., Carvalhanas, T.R.M.P., Zanetta, D.M.T. Risk factors for death from influenza A(H1N1)pdm09, State of São Paulo, Brazil, 2009. PLoS ONE, 2015. 10: e0118772.
13.
Horby P, Nguyen NY, Dunstan SJ, Kenneth Baillie J. An updated systematic review of the role of host genetics in susceptibility to influenza. Influ Other Respir Viruses. 2013;7:37–41.CrossRef
14.
Antonopoulou A, Baziaka F, Tsaganos T, Raftogiannis M, Koutoukas P, Spyridaki A, Mouktaroudi M, Kotsaki A, Savva A, Georgitsi M, et al. Role of tumor necrosis factor gene single nucleotide polymorphisms in the natural course of 2009 influenza A H1N1 virus infection. Int J Inf Dis. 2012;16:e204–8.CrossRef
15.
Maestri, A., Sortica, V.A., Tovo-Rodrigues, L., Santos, M.C., Barbagelata, L., Moraes, M.R., Alencar de Mello, W., Gusmão, L., Sousa, R.C.M., Emanuel Batista dos Santos, S. Siaα2–3Galβ1- receptor genetic variants are associated with influenza A(H1N1)pdm09 severity. PLoS ONE, 2015. 10: e0139681.
16.
Zhou J, To KK, Dong H, Cheng ZS, Lau CC, Poon VK, Fan YH, Song YQ, Tse H, Chan KH, et al. A functional variation in CD55 increases the severity of 2009 pandemic H1N1 influenza A virus infection. J Inf Dis. 2012;206:495–503.CrossRef
17.
Zúñiga, J., Buendía-Roldán, I., Zhao, Y., Jiménez, L., Torres, D., Romo, J., Ramírez, G., Cruz, A., Vargas-Alarcon, G., Sheu, C.C., et al. Genetic variants associated with severe pneumonia in A/H1N1 influenza infection. Eur Respir J, 2012. 39: https://​doi.​org/​10.​1183/​09031936.​00020611.
18.
Morales-García G, Falfán-Valencia R, García-Ramírez RA, Camarena Á, Ramirez-Venegas A, Castillejos-López M, Pérez-Rodríguez M, González-Bonilla C, Grajales-Muñíz C, Borja-Aburto V, et al. Pandemic influenza A/H1N1 virus infection and TNF, LTA, IL1B, IL6, IL8, and CCL polymorphisms in Mexican population: a case-control study. BMC Infect Dis. 2012;12:1–9.CrossRef
19.
20.
Brass AL, Huang IC, Benita Y, John SP, Krishnan MN, Feeley EM, Ryan B, Weyer JL, van der Weyden L, Fikrig E, et al. IFITM proteins mediate the innate immune response to influenza A H1N1 virus, West Nile Virus and Dengue Virus. Cell. 2009;139:1243–54.PubMedPubMedCentralCrossRef
21.
Huang IC, Bailey CC, Weyer JL, Radoshitzky SR, Becker MM, Chiang JJ, Brass AL, Ahmed AA, Chi X, Dong L, et al. Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus. PLoS Pathog. 2011;7:e1001258.PubMedPubMedCentralCrossRef
22.
Lu J, Pan Q, Rong L, He W, Liu SL, Liang C. The IFITM proteins inhibit HIV-1 infection. J Virol. 2011;85:2126–37.PubMedCrossRef
23.
Zhang YH, Zhao Y, Li N, Peng YC, Giannoulatou E, Jin RH, Yan HP, Wu H, Liu JH, Liu N, et al. Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals. Nat Commun. 2013;4:1418.PubMedCrossRef
24.
Mehrbod P, Eybpoosh S, Fotouhi F, Shokouhi Targhi H, Mazaheri V, Farahmand B. Association of IFITM3 rs12252 polymorphisms, BMI, diabetes, and hypercholesterolemia with mild flu in an Iranian population. Virol J. 2017;14:1–8.CrossRef
25.
Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet. 1997;24:1–8.PubMedCrossRef
26.
Garred P, Pressler T, Madsen HO, Frederiksen B, Svejgaard A, Høiby N, Schwartz M, Koch C. Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J Clin Invest. 1999;104:431–7.PubMedPubMedCentralCrossRef
27.
Ip WK, Chan KH, Law HK, Tso GH, Kong EK, Wong WH, To YF, Yung RW, Chow EY, Au KL, et al. Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection. J Infect Dis. 2005;191:1697–704.PubMedCrossRef
28.
Tang YW, Cleavinger PJ, Li H, Mitchell PS, Smith TF, Persing DH. Analysis of candidate-host immunogenetic determinants in herpes simplex virus-associated Mollaret’s meningitis. Clin Infect Dis. 2000;30:176–8.PubMedCrossRef
29.
McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature. 1994;371:508–10.PubMedCrossRef
30.
Mira JP, Cariou A, Grall F, Delclaux C, Losser MR, Heshmati F, Cheval C, Monchi M, Teboul JL, Riché F, et al. Association of tnf2, a tnf-α promoter polymorphism, with septic shock susceptibility and mortality: A multicenter study. J Am Med Assoc. 1999;282:561–8.CrossRef
31.
Zhang Y, Zhang Z, Cao L, Lin J, Yang Z, Zhang X. A common CD55 rs2564978 variant is associated with the susceptibility of non-small cell lung cancer. Oncotarget. 2017;8:6216–21.PubMedCrossRef
32.
Shang Y, Chai N, Gu Y, Ding L, Yang Y, Zhou J, Ren G, Hao X, Fan D, Wu K, et al. Systematic immunohistochemical analysis of the Eexpression of CD46, CD55, and CD59 in colon cancer. Arch Pathol Lab Med. 2014;138:910–9.PubMedCrossRef
33.
Bermejo-Martin JF, Martin-Loeches I, Rello J, Antón A, Almansa R, Xu L, Lopez-Campos G, Pumarola T, Ran L, Ramirez P, et al. Host adaptive immunity deficiency in severe pandemic influenza. Crit Care. 2010;14:R167–R167.PubMedPubMedCentralCrossRef
34.
Chen JZ, Huang SD, Ji CN, Pang RY, Xie Y, Xue JL. Identification, expression pattern, and subcellular location of human RIP isoforms. DNA Cell Biol. 2005;24:464–9.PubMedCrossRef
35.
Gabriel, S., Ziaugra, L., Tabbaa, D. SNP genotyping using the Sequenom MassARRAY iPLEX platform. Current Protocols in Human Genetics, 2009. 60: 2.12.1–2.12.18.
36.
Tang YW, Li H, Wu H, Shyr Y, Edwards KM. Host single-nucleotide polymorphisms and altered responses to inactivated influenza vaccine. J Infect Dis. 2007;196:1021–5.PubMedCrossRef
37.
Yang X, Tan B, Zhou X, Xue J, Zhang X, Wang P, Shao C, Li Y, Li C, Xia H, et al. Interferon-inducible transmembrane protein 3 genetic variant rs12252 and influenza susceptibility and severity: a meta-analysis. PLoS ONE. 2015;10:e0124985.PubMedPubMedCentralCrossRef
38.
Randolph AG, Yip WK, Allen EK, Rosenberger CM, Agan AA, Ash SA, Zhang Y, Bhangale TR, Finkelstein D, Cvijanovich NZ, et al. Evaluation of IFITM3 rs12252 association with severe pediatric influenza Iinfection. J Infect Dis. 2017;216:14–21.PubMedPubMedCentralCrossRef
39.
Wellington D, Laurenson-Schafer H, Abdel-Haq A, Dong T. IFITM3: How genetics influence influenza infection demographically. Biomedical Journal. 2019;42:19–26.PubMedPubMedCentralCrossRef
40.
Kalliolias GD, Ivashkiv LB. TNF biology, pathogenic mechanisms and emerging therapeutic strategies. Nat Rev Rheumatol. 2016;12:49–62.PubMedCrossRef
41.
McKinstry KK, Strutt TM, Buck A, Curtis JD, Dibble JP, Huston G, Tighe M, Hamada H, Sell S, Dutton RW, et al. IL-10 deficiency unleashes an influenza-specific Th17 response and enhances survival against high-dose challenge. Journal of Immunology. 2009;182:7353–63.CrossRef
42.
43.
García-Ramírez RA, Ramírez-Venegas A, Quintana-Carrillo R, Camarena ÁE, Falfán-Valencia R, Mejía-Aranguré JM. TNF, IL6, and IL1B polymorphisms are associated with severe influenza A (H1N1) virus infection in the Mexican population. PLoS ONE. 2015;10:e0144832.PubMedPubMedCentralCrossRef
44.
Rogo LD, Rezaei F, Marashi SM, Yekaninejad MS, Naseri M, Ghavami N, Mokhtari-Azad T. Seasonal influenza A/H3N2 virus infection and IL-1Β, IL-10, IL-17, and IL-28 polymorphisms in Iranian population. J Med Virol. 2016;88:2078–84.PubMedCrossRef
45.
Keshavarz M, Namdari H, Farahmand M, Mehrbod P, Mokhtari-Azad T, Rezaei F. Association of polymorphisms in inflammatory cytokines encoding genes with severe cases of influenza A/H1N1 and B in an Iranian population. Virology Journal. 2019;16:1–10.CrossRef
46.
Zhao N, Chen H-L, Chen Z-Z, Li J, Chen Z-B. IL-10-592 polymorphism is associated with IL-10 expression and severity of enterovirus 71 infection in chinese children. J Clin Virol. 2017;95:42–6.PubMedCrossRef
47.
Ferdinands JM, Denison AM, Dowling NF, Jost HA, Gwinn ML, Liu L, Zaki SR, Shay DK. A Pilot study of host genetic variants associated with influenza-associated deaths among children and young adults. Emerg Infect Dis. 2011;17:2294–302.PubMedPubMedCentralCrossRef
48.
Choudhary ML, Alagarasu K, Chaudhary U, Kawale S, Malasane P, Gurav YK, Padbidri V, Kadam D, Sangle SA, Salvi S, et al. Association of single nucleotide polymorphisms in TNFA and IL10 genes with disease severity in influenza A/H1N1pdm09 virus infections: A study from Western India. Viral Immunol. 2018;31:683–8.PubMedCrossRef
49.
Super M, Gillies SD, Foley S, Sastry K, Schweinle JE, Silverman VJ, Ezekowitz RAB. Distinct and overlapping functions of allelic forms of human mannose binding protein. Nat Genet. 1992;2:50–5.PubMedCrossRef
50.
Gallagher PM, Lowe G, Fitzgerald T, Bella A, Greene CM, McElvaney NG, O’Neill SJ. Association of IL-10 polymorphism with severity of illness in community acquired pneumonia. Thorax. 2003;58:154–6.PubMedPubMedCentralCrossRef
51.
Gomi K, Tokue Y, Kobayashi T, Takahashi H, Watanabe A, Fujita T, Nukiwa T. Mannose-binding lectin gene polymorphism is a modulating factor in repeated respiratory infections. Chest. 2004;26:95–9.CrossRef
52.
53.
Ornelas, A.M.d.M., Xavier-de-Carvalho, C., Alvarado-Arnez, L.E., Ribeiro-Alves, M., Rossi, Á.D., Tanuri, A., de Aguiar, R.S., Moraes, M.O., and Cardoso, C.C. Association between MBL2 haplotypes and dengue severity in children from Rio de Janeiro, Brazil. Memorias do Instituto Oswaldo Cruz, 2019. 114: e190004.
54.
55.
Boruchov AM, Heller G, Veri M-C, Bonvini E, Ravetch JV, Young JW. Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions. J Clin Investig. 2005;115:2914–23.PubMedCrossRefPubMedCentral
56.
Duan J, Lou J, Zhang Q, Ke J, Qi Y, Shen N, Zhu B, Zhong R, Wang Z, Liu L, et al. A genetic variant rs1801274 in FCGR2A as a potential risk marker for Kawasaki disease: a case-control study and meta-analysis. PLoS ONE. 2014;9:e103329.PubMedPubMedCentralCrossRef
57.
Bouglé A, Max A, Mongardon N, Grimaldi D, Pène F, Rousseau C, Chiche J-D, Bedos J-P, Vicaut E, Mira J-P. Protective effects of FCGR2A polymorphism in invasive pneumococcal diseases. Chest. 2012;142:1474–81.PubMedCrossRef
58.
Chatzopoulou F, Gioula G, Kioumis I, Chatzidimitriou D, Exindari M. Identification of complement-related host genetic risk factors associated with influenza A(H1N1)pdm09 outcome: challenges ahead. Med Microbiol Immunol. 2019;208:631–40.PubMedCrossRef
59.
Arcanjo AC, Mazzocco G, de Oliveira SF, Plewczynski D, Radomski JP. Role of the host genetic variability in the influenza A virus susceptibility. Acta Biochim Pol. 2014;61:403–19.PubMedCrossRef
60.
Zheng YH, Yu HF, Peterlin BM. Human p32 protein relieves a post-transcriptional block to HIV replication in murine cells. Nat Cell Biol. 2003;5:611–8.PubMedCrossRef
61.
Lee N, Cao B, Ke C, Lu H, Hu Y, Tam CHT, Ma RCW, Guan D, Zhu Z, Li H, et al. IFITM3, TLR3, and CD55 gene SNPs and cumulative genetic risks for severe outcomes in Chinese patients with H7N9/H1N1pdm09 influenza. J Infect Dis. 2017;216:97–104.PubMedCrossRef
62.
Park J, Seo T, Kim H, Choe J. Sumoylation of the novel protein hRIP{beta} is involved in replication protein A deposition in PML nuclear bodies. Mol Cell Biol. 2005;25:8202–14.PubMedPubMedCentralCrossRef
63.
Ganna A. The Covid-Host Genetics Initiative; a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic. Eur J Hum Genet. 2020;28:715–8.CrossRef
64.
Kachuri, L., Francis, S.S., Morrison, M., Boss, amp, amp, eacute, Y., Cavazos, T.B., Rashkin, S.R., Ziv, E., et al. The landscape of host genetic factors involved in infection to common viruses and SARS-CoV-2. MedRxiv, 2020. Preprint: 2020.05.01.20088054.
Metadata
Title
Association of the host genetic factors, hypercholesterolemia and diabetes with mild influenza in an Iranian population
Authors
Parvaneh Mehrbod
Sana Eybpoosh
Behrokh Farahmand
Fatemeh Fotouhi
Majid Khanzadeh Alishahi
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2021
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-021-01486-3

Other articles of this Issue 1/2021

Virology Journal 1/2021 Go to the issue

Research

Inhibition of Japanese encephalitis virus proliferation by long non-coding RNA SUSAJ1 in PK-15 cells

Research

Temporal phylogeny and molecular characterization of echovirus 30 associated with aseptic meningitis outbreaks in China

Research

High-risk human papillomavirus detection in self-collected vaginal samples compared with healthcare worker collected cervical samples among women attending gynecology clinics at a tertiary hospital in Pretoria, South Africa

Research

Pathogenicity of Seneca Valley virus in pigs and detection in Culicoides from an infected pig farm

Methodology

One-step real-time multiplex reverse transcription-polymerase chain reaction assay with melt curve analysis for detection of potato leafroll virus, potato virus S, potato virus X, and potato virus Y

Short report

Genome-wide identification of endogenous viral sequences in alfalfa (Medicago sativa L.)
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits